This article summarizes the evolution of the screening deck at the Novartis Institutes for BioMedical Research (NIBR). Historically, the screening deck was an assembly of all …
W Decurtins, M Wichert, RM Franzini, F Buller… - Nature protocols, 2016 - nature.com
DNA-encoded chemical libraries (DECLs) are collections of organic compounds that are individually linked to different oligonucleotides, serving as amplifiable identification …
A Karawajczyk, F Giordanetto, J Benningshof… - Drug Discovery …, 2015 - Elsevier
Highlights•High-quality compound collections are a main determinant of drug discovery success.•Generation of relevant collections is a significant challenge for any …
Highlights•A critical assessment of 16 million commercially available compounds.•A comparison of vendors' offerings.•How the offerings have evolved to meet modern …
GHS Dreiman, M Bictash, PV Fish… - … the Science of Drug …, 2021 - journals.sagepub.com
Iterative screening is a process in which screening is done in batches, with each batch filled by using machine learning to select the most promising compounds from the library based …
CA Reiher, DP Schuman, N Simmons… - ACS Medicinal …, 2021 - ACS Publications
DNA-encoded library (DEL) screens have emerged as a powerful hit-finding tool for a number of biological targets. In this Innovations article, we review published hit-to-lead …
L Hoffer, YV Voitovich, B Raux, K Carrasco… - Journal of medicinal …, 2018 - ACS Publications
Over the past few decades, hit identification has been greatly facilitated by advances in high- throughput and fragment-based screenings. One major hurdle remaining in drug discovery …
LH Mervin, Q Cao, IP Barrett, MA Firth… - ACS chemical …, 2016 - ACS Publications
While mechanisms of cytotoxicity and cytostaticity have been studied extensively from the biological side, relatively little is currently understood regarding areas of chemical space …
CS Hansel, DL Plant, GA Holdgate, MJ Collier… - Drug Discovery …, 2022 - Elsevier
Challenged by ageing infrastructure and increasingly demanding screening cascades, AstraZeneca High Throughput Screening department has developed advanced automation …